Skip to main content
Premium Trial:

Request an Annual Quote

Mississippi Man Pleads Guilty to $51M Healthcare Fraud Scheme

NEW YORK – The US Attorney's Office for the District of New Jersey said Wednesday that a Mississippi man has pleaded guilty to a role in a $51 million healthcare fraud scheme.

According to the government, Keaton Langston and others paid kickbacks and bribes in exchange for doctor's orders for genetic cancer screening tests, durable medical equipment, and compounded medicines that were then filled by companies they either owned, operated, or had a financial interest in, including a laboratory.

They concealed these payments by making it appear they were for legitimate marketing and referral purposes.

The laboratory, pharmacies, and DME companies billed Medicare and other healthcare benefit programs approximately $51 million for tests and orders produced by the scheme. According to the DOJ, Langston received approximately $10 million from these reimbursements.

Langston pleaded guilty in US District Court for the District of New Jersey to conspiracy to commit healthcare fraud. The charge is punishable by a maximum of 10 years in prison and a fine of $250,000 or twice the gross gain or loss from the offense, whichever is greater. Sentencing is scheduled for Oct. 1, 2024.